764
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Kratom use as more than a “self-treatment”

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , & show all
Pages 684-694 | Received 12 Jan 2022, Accepted 22 May 2022, Published online: 29 Jun 2022

References

  • Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH.Self-Treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103:1048–50.
  • Boyer EW, Babu KM, Macalino GE.Self-Treatment of opioid withdrawal with a dietary supplement. Kratom Am J Addict. 2007;16:352–56.
  • Grundmann O. Patterns of kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend. 2017;176:63–70.
  • [accessed 2021 November 2]. https://legislativeanalysis.org/regulation-of-kratom-in-america/
  • Smith KE, Lawson T. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug Alcohol Depend. 2017;180:340–48.
  • Swogger MT, Hart E, Erowid F, Erowid E, Trabold N, Yee K, Parkhurst KA, Priddy BM, Walsh Z.Experiences of kratom users: a qualitative analysis. J Psychoactive Drugs. 2015;47:360–67.
  • Bath R, Bucholz T, Buros AF, Singh D, Smith KE, Veltri CA, Grundmann O.Self-Reported health diagnoses and demographic correlates with kratom use: results from an online survey. J Addict Med. 2020;14:244–52.
  • Coe MA, Pillitteri JL, Sembower MA, Gerlach KK, Henningfield JE. Kratom as a substitute for opioids: results from an online survey. Drug Alcohol Depend. 2019;202:24–32.
  • Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020;208:107849.
  • Swogger MT, Walsh Z. Kratom use and mental health: a systematic review. Drug Alcohol Depend. 2018;183:134–40.
  • Singh D, Narayanan S, Muller CP, Swogger MT, Chear NJY, Dzulkapli EB, Yusoff NSM, Ramachandram DS, Leon F, McCurdy CR, et al. Motives for using kratom (Mitragyna speciosa Korth.) among regular users in Malaysia. J Ethnopharmacol. 2019;233:34–40.
  • Singh D, Narayanan S, Vicknasingam B.Traditional and non-traditional uses of Mitragynine (kratom): a survey of the literature. Brain Res Bull. 2016;126:41–46.
  • Singh D, Narayanan S, Vicknasingam B, Prozialeck WC, Smith KE, Corazza O, Henningfield JE, Grundmann O. The use of kratom (Mitragyna speciosa Korth.) among people who co-use heroin and methamphetamine in Malaysia. J Addict Med. 2021;16:223-22.
  • Singh D, Yeou Chear NJ, Narayanan S, Leon F, Sharma A, McCurdy CR, Avery BA, Balasingam V. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. J Ethnopharmacol. 2020;249:112462.
  • Saingam D, Assanangkornchai S, Geater AF, Balthip Q.Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in Southern Thailand: a qualitative study. Int J Drug Policy. 2013;24:351–58.
  • Smith KE, Rogers JM, Schriefer D, Grundmann O. Therapeutic benefit with caveats?: analyzing social media data to understand the complexities of kratom use. Drug Alcohol Depend. 2021;226:108879.
  • Smith KE, Dunn KE, Grundmann O, Garcia-Romeu A, Rogers JM, Swogger MT, Epstein DH. Social, psychological, and substance use characteristics of US adults who use kratom: initial findings from an online, crowdsourced study. Exp Clin Psychopharmacol. 2021;21:283–288.
  • Vicknasingam B, Narayanan S, Beng GT, Mansor SM.The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy. 2010;21:283–88.
  • Grundmann O, Veltri CA, Morcos D, Knightes D, Smith KE, Rogers JM. How essential is kratom availability and use during Covid-19? Use pattern analysis based on survey and social media data. Subst Abus. 2021.
  • Prevete E, Hupli A, Marrinan S, Singh D, D’-Udine B, Bersani G, Kuypers K, Ramaekers J, Corazza O. Exploring the use of kratom (Mitragyna speciosa) via the YouTube data tool: a novel netnographic analysis. Emerging Trends in Drugs, Addictions, and Health. 2021;1:100007.doi:10.1016/j.etdah.2021.100007.
  • Smith KE, Rogers JM, Strickland JC, Epstein DH.When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use. Am J Drug Alcohol Abuse. 2021;47:455–66.
  • Chandler J, Shapiro D. Conducting clinical research using crowdsourced convenience samples. Annu Rev Clin Psychol. 2016;12:53–81.
  • Miller JD, Crowe M, Weiss B, Maples-Keller JL, Lynam DR.Using online, crowdsourcing platforms for data collection in personality disorder research: the example of amazon’s mechanical turk. Personal Disord. 2017;8:26–34.
  • Mortensen K, Hughes TL.Comparing amazon’s mechanical turk platform to conventional data collection methods in the health and medical research literature. J Gen Intern Med. 2018;33:533–38.
  • Peer E, Vosgerau J, Acquisti A.Reputation as a sufficient condition for data quality on amazon mechanical turk. Behav Res Methods. 2014;46:1023–31.
  • Shank DB.Using crowdsourcing websites for sociological research: the case of amazon mechanical turk. Am Sociol. 2016;47:47–55.doi:10.1007/s12108-015-9266-9.
  • Sheehan KB.Crowdsourcing research: data collection with amazon’s mechanical turk. Commun Monogr. 2018;85:140–56.doi:10.1080/03637751.2017.1342043.
  • Strickland JC, Lile JA, Stoops WW. Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behav Processes. 2017;140:33–40.
  • Strickland JC, Stoops WW.Utilizing content-knowledge questionnaires to assess study eligibility and detect deceptive responding. Am J Drug Alcohol Abuse. 2020;46:149–57.
  • Kruegel AC, Grundmann O.The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018;134:108–20.doi:10.1016/j.neuropharm.2017.08.026.
  • Grundmann O, Babin JK, Henningfield JE, Garcia-Romeu A, Kruegel AC, Prozialeck WC, Raffa RB, Singh D, Smith KE.kratom use in the United States: a diverse and complex profile. Addiction. 2021;116:202–03.
  • Henningfield JE, Fant RV, Wang DW.The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research. Psychopharmacology. 2018;235:573–89.doi:10.1007/s00213-017-4813-4.
  • Rogers JM, Smith KE, Strickland JC, Epstein DH. Kratom use in the US: both a regional phenomenon and a white middle-class phenomenon? Evidence from NSDUH 2019 and an online convenience sample. Frontiers in Phamacology. 2021;12:3551.
  • Swogger M, Smith K, Garcia-Romeu A, Grundmann O, Veltri C, Henningfield J, Busch L. Understanding kratom use: a guide for healthcare providers. Front Pharmacol. 2022;13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.